SOPHARMA AD (72/2022) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 27 September 2022.
Report no 72/2022
- 28.09.2022, 13:17
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (70/2022) Sales revenues for August 2022
Report no 70/2022- 07.09.2022, 13:48
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (69/2022) Consolidated financial report according to IFRS as at 30 June 2022
Report no 69/2022- 29.08.2022, 13:22
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (68/2022) Results from the public offering to the shareholders of Sopharma properties REIT
Report no 68/2022- 26.08.2022, 09:50
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (67/2022) Sales revenues for July 2022
Report no 67/2022- 05.08.2022, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (66/2022) Individual financial report according to IFRS as at 30 June 2022
Report no 66/2022- 01.08.2022, 13:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (65/2022) Notification for initiation of a tender offering to the shareholders of Sopharma properties REIT
Report no 65/2022- 29.07.2022, 16:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (64/2022) The Board of Directors of "Sopharma" AD adopted a decision to issue a second warrants issue
Report no 64/2022- 07.07.2022, 12:47
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (63/2022) Sales revenues for June 2022
Report no 63/2022- 05.07.2022, 13:01
- Kategoria: Biznes i finanse
- Źródło: ESPI
